Oral insulin-sensitizing agents such as metformin may act by decreasing the peripheral resistance to plasma insulin and hence cause ovulation to resume, restore metabolic and hormonal derangements, and improve fertility in PCOS patients. This evidence concerns the gene INS and polycystic ovary syndrome.